Moderna LLC — Form D/A
Moderna LLC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2014-01-23. The offering totals $135.0M, of which $135.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-01-23
- Form: D/A
- Accession: 0001592247-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $135.0M
- Amount sold: $135.0M
- Investors: 40
- Date of first sale: 2013-11-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-206659
Issuer
- Name: Moderna LLC
- CIK: 0001592247
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 200 TECH SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-714-6500
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Lorence Kim | Executive Officer | Lexington, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Robert Carpenter | Director | Vancouver, A1 |
| John Mendlein | Director | San Diego, CA |
| James Kasinger | Executive Officer | Zug, V8 |
| PETER HUTT | Director | MEDFORD, MA |
| Noubar Afeyan | Director | Cambridge, MA |
| Stephane Bancel | Director | Cambridge, MA |
| Stephane Bancel | Executive Officer | Cambridge, MA |
| Henri Termeer | Director | Cambridge, MA |
| Lee Babiss | Director | Cambridge, MA |
| Theo Melas-Kyriazi | Director | Cambridge, MA |
Other filings by this issuer (2)
More